Zenotech Laboratories Limited

BSE:532039 Stock Report

Market Cap: ₹4.7b

Zenotech Laboratories Balance Sheet Health

Financial Health criteria checks 6/6

Zenotech Laboratories has a total shareholder equity of ₹931.7M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹1.1B and ₹147.6M respectively. Zenotech Laboratories's EBIT is ₹72.6M making its interest coverage ratio -7.7. It has cash and short-term investments of ₹219.2M.

Key information

0%

Debt to equity ratio

₹0

Debt

Interest coverage ratio-7.7x
Cash₹219.24m
Equity₹931.65m
Total liabilities₹147.58m
Total assets₹1.08b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 532039's short term assets (₹304.5M) exceed its short term liabilities (₹126.1M).

Long Term Liabilities: 532039's short term assets (₹304.5M) exceed its long term liabilities (₹21.4M).


Debt to Equity History and Analysis

Debt Level: 532039 is debt free.

Reducing Debt: 532039 has no debt compared to 5 years ago when its debt to equity ratio was 70.6%.

Debt Coverage: 532039 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 532039 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies